Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1997 1
2002 8
2003 11
2004 12
2005 12
2006 10
2007 8
2008 7
2009 8
2010 12
2011 9
2012 8
2013 9
2014 4
2015 7
2016 6
2017 7
2018 6
2019 9
2020 6
2021 9
2022 0
Text availability
Article attribute
Article type
Publication date

Search Results

157 results
Results by year
Filters applied: . Clear all
Page 1
Bivalent HIV-1 fusion inhibitors based on peptidomimetics.
Kobayakawa T, Ebihara K, Tsuji K, Kawada T, Fujino M, Honda Y, Ohashi N, Murakami T, Tamamura H. Kobayakawa T, et al. Among authors: tamamura h. Bioorg Med Chem. 2020 Dec 15;28(24):115812. doi: 10.1016/j.bmc.2020.115812. Epub 2020 Oct 9. Bioorg Med Chem. 2020. PMID: 33157478
Chloroalkene dipeptide isosteres as peptidomimetics.
Kobayakawa T, Tamamura H. Kobayakawa T, et al. Among authors: tamamura h. Methods Enzymol. 2021;656:191-239. doi: 10.1016/bs.mie.2021.04.015. Epub 2021 May 21. Methods Enzymol. 2021. PMID: 34325787
[Peptidomimetic-based medicinal chemistry].
Narumi T, Tamamura H. Narumi T, et al. Among authors: tamamura h. Seikagaku. 2010 Jun;82(6):515-23. Seikagaku. 2010. PMID: 20662260 Review. Japanese. No abstract available.
Potent leads based on CA-19L, an anti-HIV active HIV-1 capsid fragment.
Tsuji K, Wang R, Kobayakawa T, Owusu KB, Fujino M, Kaneko M, Yamamoto N, Murakami T, Tamamura H. Tsuji K, et al. Among authors: tamamura h. Bioorg Med Chem. 2021 Jan 15;30:115923. doi: 10.1016/j.bmc.2020.115923. Epub 2020 Dec 7. Bioorg Med Chem. 2021. PMID: 33316719
157 results